Endo’s Par Delivers On Nevakar Alliance With First Launch

Launch Of Pre-Mixed Ephedrine Sulfate Follows 2018 Deal With 505(b)(2) Specialist

 
• By Dave Wallace

Endo’s Par has announced the first launch under a longstanding US collaboration with 505(b)(2) specialist Nevakar, in the form of pre-mixed ephedrine sulfate injection in a ready-to-use 50mg/10ml single-use vial.

black chalk board with lettering ephedrine
Pre-mixed ephedrine sulfate is the first launch through Endo’s alliance with Nevakar • Source: LightField Studios Inc. / Alamy Stock Photo

More from Products

More from Generics Bulletin